SCHEMBL24418926

SCHEMBL24418926

CCC(CC)c1cc(N[C@H]2CC[C@H](NCCOCCOCCOCCN)C2)n2nccc2n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK9 P50750 20/20 0.66
▸ CCNT1 O60563 19/20 0.66
▸ CDK4 P11802 7/20 0.66
▸ CCND1 P24385 7/20 0.66
▸ CDK7 P50613 5/20 0.66
▸ CDK2 P24941 5/20 0.66
▸ CCNH P51946 4/20 0.66
▸ CCNE1 P24864 4/20 0.66
▸ CCNA1 P78396 4/20 0.66
▸ CDK3 Q00526 4/20 0.66
▸ CDK1 P06493 3/20 0.66
▸ CCNA2 P20248 3/20 0.66
▸ CDK5 Q00535 3/20 0.66
▸ CDK5R1 Q15078 3/20 0.66
▸ CDK6 Q00534 2/20 0.66
▸ CDK13 Q14004 2/20 0.66
▸ CDK12 Q9NYV4 2/20 0.66
▸ CCNK O75909 1/20 0.66
▸ CDK14 O94921 1/20 0.66
▸ CYP1A2 P05177 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24418930 1.00 CDK9 (0.66) CDK9CCNT1CDK4CCND1CDK7
Hydrochloric Acid SCHEMBL29558414 0.99 CDK9 (0.65) CDK9CCNT1CDK4CCND1CDK7
SCHEMBL24418845 0.88 CDK9 (0.59) CDK9CCNT1CDK4CCND1CDK7
SCHEMBL24418931 0.88 CDK9 (0.59) CDK9CCNT1CDK4CCND1CDK7
SCHEMBL24418928 0.85 CCNT1 (0.56) CDK9CCNT1CDK4CCND1CDK7
SCHEMBL24418932 0.85 CCNT1 (0.56) CDK9CCNT1CDK4CCND1CDK7
SCHEMBL24418611 0.81 CCNT1 (0.78) CDK9CCNT1CDK4CCND1CDK7
SCHEMBL29558215 0.81 CCNT1 (0.71) CDK9CCNT1CDK4CCND1CDK7
Istisociclib SCHEMBL21877722 0.80 CDK9 (1.00) CDK9CCNT1CDK4CCND1CDK7
Istisociclib SCHEMBL30467857 0.80 CDK9 (1.00) CDK9CCNT1CDK4CCND1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022098843-A1 COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY Kronos Bio, Inc. (US) 2022-05-12 — — WO disclosed
Send feedback